Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chemoresistance”

32 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 32 results

Not applicableActive Not RecruitingNCT06642506
What this trial is testing

Oncometabolome and MALDI-MSI in Upper GI Carcinomas - Chemosensitivity in Esophageal Carcinoma

Who this might be right for
Esophagus AdenocarcinomaEsophagus CancerMetabolome+5 more
Ludwig-Maximilians - University of Munich 20
Not applicableUnknownNCT01889407
What this trial is testing

Idarubicin Overcomes MDR1 Induced Chemoresistance With Higher Induction Remission Rate and Quality Than Daunorubicin in Acute Myeloid Leukemia Patients

Who this might be right for
Acute Myeloid Leukemia
Nanfang Hospital, Southern Medical University 94
Testing effectiveness (Phase 2)Looking for participantsNCT05082519
What this trial is testing

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

Who this might be right for
B-cell Acute Lymphoblastic LeukemiaObesity
Etan Orgel 240
Not applicableUnknownNCT01921699
What this trial is testing

Macrophages Effect on Chemoresistance

Who this might be right for
the Focus of the Study is Macrophage-induced Chemoresistance in Pancreatic Carcinoma Cells During Chemotherapy.
Rambam Health Care Campus 2
Not applicableStudy completedNCT02878122
What this trial is testing

Study of Predictive Factors of Chemoresistance in Ovarian Cancer

Who this might be right for
Ovarian Cancer
Rennes University Hospital 13
Large-scale testing (Phase 3)Looking for participantsNCT05281471
What this trial is testing

Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)

Who this might be right for
Platinum-resistant Ovarian CancerPlatinum-refractory Ovarian CancerFallopian Tube Cancer+4 more
Genelux Corporation 186
Not applicableEnded earlyNCT02164942
What this trial is testing

LCI-GU-BLA-SPEC-001: Aurora Kinase Expression in Muscle-Invasive Bladder Cancer

Who this might be right for
Bladder Cancer
Wake Forest University Health Sciences 6
Testing effectiveness (Phase 2)Active Not RecruitingNCT00496795
What this trial is testing

Predictors for Response to Dose-dense Docetaxel and Epirubicin Breast Cancer

Who this might be right for
Stage III Breast Cancer AJCC V7
University of Bergen 100
Not applicableStudy completedNCT00551798
What this trial is testing

Prediction of the Response to Chemotherapy by Tomoscintigraphie the MIBI in the Balance Sheet Pre Hodgkin's Disease and Lymphoma Malins High Grade

Who this might be right for
Hodgkin's DiseaseMalignant Lymphomas High GradeChemoresistance
University Hospital, Limoges 90
Not applicableLooking for participantsNCT04846933
What this trial is testing

Multi-layer Data to Improve Diagnosis, Predict Therapy Resistance and Suggest Targeted Therapies in HGSOC

Who this might be right for
High Grade Ovarian Serous AdenocarcinomaHigh Grade Serous Carcinoma
Turku University Hospital 200
Not applicableWithdrawnNCT04266353
What this trial is testing

Effect of Resveratrol on Serum IGF2 Among African American Women

Who this might be right for
Chemoprevention
Loma Linda University
Not applicableActive Not RecruitingNCT02758652
What this trial is testing

Molecular Mechanisms Leading to Chemoresistance in Epithelial Ovarian Cancer

Who this might be right for
Ovarian Cancer
Tampere University Hospital 160
Not applicableLooking for participantsNCT05038358
What this trial is testing

Tumor Immune Microenvironment Involvement in Colorectal Cancer Chemoresistance Mechanisms

Who this might be right for
Primary TumorColon Tumor
University Hospital, Grenoble 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06218524
What this trial is testing

The Effectiveness of HP and TMZ Synergism on Adult Recurrence GBM

Who this might be right for
Glioblastoma Multiforme
Southern Medical University, China 200
Not applicableStudy completedNCT00965276
What this trial is testing

Relationship of pAKT to Survival in Patients With Node-Positive Breast Cancer

Who this might be right for
Breast Cancer
National Cancer Institute (NCI) 2,500
Not applicableUnknownNCT06348693
What this trial is testing

Development of Therapeutic Approaches Modulating Molecular Targets Implicated on Cancer Stem Cell-related Aggressiveness

Who this might be right for
GlioblastomaGliomaGlioma Glioblastoma Multiforme
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico 400
Very early researchEnded earlyNCT01261299
What this trial is testing

Clinical Study of Microdosing Carboplatin in Lung or Bladder Cancer

Who this might be right for
Carcinoma, Non-Small-Cell LungUrinary Bladder Neoplasms
University of California, Davis 21
Not applicableUnknownNCT03488901
What this trial is testing

Chemoresistance of Trophoblastic Tumors

Who this might be right for
Trophoblastic Tumor
Hospices Civils de Lyon 72
Not applicableStudy completedNCT03672682
What this trial is testing

SMOLY : Phenotype and Functions of Monocyte Subtypes in High Grade B Lymphoma: Towards New Biomarkers?

Who this might be right for
DLBCL
Rennes University Hospital 45
Not applicableWithdrawnNCT02414100
What this trial is testing

Patient Derived Cancer Cell Lines in Identifying Molecular Changes in Patients With Previously Untreated Pancreatic Cancer Receiving Gemcitabine Hydrochloride-Based Chemotherapy

Who this might be right for
Pancreatic Ductal AdenocarcinomaStage IA Pancreatic CancerStage IB Pancreatic Cancer+4 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Load More Results